ACG 2026 Annual Scientific Meeting

Join GI physicians from the U.S. and around the world for the ACG Annual Scientific Meeting. ACG 2026 will deliver the latest clinical information on timely topics in gastroenterology and hepatology.

Wednesday, October 14, 2026 | All events are offered in Central Time (CT).
8:30 am –
12:15 pm
Annual Scientific Meeting
8:30 am –
10:15 am
Simultaneous Plenary Sessions 4 (4A and 4B)
10:15 am –
10:20 am
Break
10:20 am –
10:50 am
LIVESTREAM
David Y. Graham Lecture

Introduced By: William D. Chey, MD, MACG, ACG President

Modern Advanced Endoscopy – Looking Back to Move Forward
Allison R. Schulman, MD, MPH, FACG
Discuss the history of advanced endoscopy, current therapeutic and interventional techniques, and the future of this field.

10:50 am –
11:00 am
Break
11:00 am –
12:15 pm
Simultaneous Symposia: Session 5

LIVESTREAM
Symposium 5A: Best Practices in Pancreatic Diseases: What Every Gastroenterologist Needs to Know
Moderator: Andrew T. Catanzaro, MD, FACG

  • Pancreatic Cancer Screening: Who, When, How
    Aimee L. Lucas, MD, MS, FACG
    Identify patients at increased risk for pancreatic cancer, describe current evidence-based screening recommendations, and apply appropriate screening and surveillance strategies using available modalities.
  • Pancreatic Cysts in 2026: What’s New in the Guidelines
    Andrew T. Catanzaro, MD, FACG
    Classify pancreatic cystic lesions, identify high-risk and worrisome features, and apply current guideline-based strategies for surveillance, EUS evaluation, and referral for surgical management.
  • Practical Guide to Exocrine Pancreatic Insufficiency Management
    Bradford J. Chong, MD
    Summarize EPI management, including pancreatic enzyme replacement therapy, nutritional status monitoring and symptom response, and health maintenance strategies to optimize long-term patient outcomes.

Symposium 5B: Doc, I Wrote Down a Few Questions: A Rapid Fire Discussion With the Experts on What IBD Patients Want to Know
Moderator: Jacob M. Skeans, MD
Panel: Jessica R. Allegretti, MD, MPH, FACG; Michael T. Dolinger, MD; Oriana Mazorra Damas, MD

  • Will These Probiotics Heal My Inflammation? Role of Microbiome-Directed Therapy
    Evaluate the role of microbiome-directed therapies, including probiotics, in the management of IBD.
  • Do I Have to Do Another Scope? Emerging Role of Intestinal Ultrasound in IBD Care
    Describe the emerging role of intestinal ultrasound in assessing and monitoring inflammatory bowel disease.
  • What’s the Skinny on GLP1s and IBD?
    Discuss role of GLP-1 agonist use in patients with IBD.
  • Can I Just Eat Better? Using Nutrition as Therapy in Adults With IBD
    Analyze the evidence for and limitations of dietary interventions in inflammatory bowel disease.
  • Did You Just Say This Medication Can Cause Cancer? Advanced Therapies and Cancer Risks
    Evaluate the data regarding malignancy risks in current IBD therapies.
12:15 pm Annual Scientific Meeting Adjourns